This session, chaired by Professor Simona Parrinello from University College London (UK), will focus on the importance of translational science in cancer research, specifically in the study of brain cancer, including primary brain tumours (such as glioblastoma) and brain metastasis. Dr Joan Seoane from the Vall d’Hebron Institute of Oncology (Spain), whose work has been recognised with several awards, will share how his multidisciplinary team of researchers have been looking at the molecular processes that appear with the onset of brain cancer and trying to find treatments to combat it. Working in a hospital environment, Dr Seoane has been able to lead studies close to the reality of patients, and develop patient-derived models to detect the molecular mechanisms involved in tumour initiation and progression. His team have also been able to derive some of the newly discovered mechanisms to other tumour types finding that, in some cases, the same process takes place in diverse cancers.
Who should attend?
Anyone interested or working in brain tumour research and/or translational research including patients and carers formally involved in research, scientists, medical/clinical oncologists, surgeons, early career researchers, nurses, allied health professionals, PhD and undergraduate students, research teams and research managers/funders.